A real-world study assessing effectiveness and safety of dupilumab
Latest Information Update: 29 Aug 2022
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 29 Aug 2022 New trial record
- 01 Aug 2022 Results published in the Journal of Dermatological Treatment